There are an estimated 55 million children in China with undiagnosed rare diseases. We are working with two of the largest and most prestigious pediatric hospitals – Fudan and Ruijin – to address this pressing medical need. By applying the power of our renowned rare disease diagnostics and China variant knowledgebase, we expect to rapidly accelerate the number of cases solved and improve the treatment and prospects of patients. Using our platform will further accelerate this process by leveraging the China Precision Medicine Cloud that we have launched with Huawei. It enables experts to interpret sequences from patients in other parts of the country and creates a cumulative data and knowledgebase of disease variants in the Chinese population.